Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factorial design considerations.

Stephanie Green1, Ping-Yu Liu, Janet O'Sullivan

  • 1Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, MP 557, PO Box 19024, Seattle, WA 98109-1024, USA.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|August 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Same author

Glaucoma Agreement in New Zealand (GAINZ).

Clinical & experimental optometry·2024
Same author

The application of strategy based on LSTM for the short-term prediction of PM<sub>2.5</sub> in city.

The Science of the total environment·2023
Same author

Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak.

American journal of ophthalmology case reports·2022
Same author

Case Report: Severe rash/desquamation induced by sorafenib in an uHCC patient and its clinical management.

Frontiers in pharmacology·2022
Same author

A novel approach to studying early knee osteoarthritis illustrates that bilateral medial tibiofemoral osteoarthritis is a heritable phenotype: an offspring study.

Rheumatology international·2022
Same journal

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
See all related articles

Factorial designs in clinical trials can increase efficiency but may lead to incorrect conclusions. Careful consideration of statistical interactions and multiple testing is crucial for reliable results.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Experimental Design

Background:

  • Factorial designs offer potential for testing multiple research questions within a single clinical trial.
  • Common analytical approaches often assume no statistical interactions and do not adjust for multiple testing.
  • This study evaluates the balance between increased efficiency and the risk of erroneous conclusions in factorial trials.

Purpose of the Study:

  • To investigate the trade-offs associated with using factorial designs in clinical trials.
  • To assess the impact of statistical interactions and multiple testing adjustments on trial outcomes.
  • To determine the probability of selecting the correct treatment arm under different analytical approaches.

Main Methods:

  • A simulation study using a 2x2 factorial design (e.g., observation vs. chemotherapy vs. radiation therapy vs. combination).

Related Experiment Videos

  • Simulations were conducted under various conditions, including treatment effects and the presence or absence of statistical interaction.
  • Three analysis methods were compared: no interaction assumed, interaction tested first, and interaction tested with multiple testing adjustment.

    • Main Results:

    • No single analytical approach proved superior across all scenarios.
    • Testing for statistical interactions yielded benefits in some situations but proved detrimental in others.
    • Factorial designs sometimes improved efficiency, but in certain scenarios, all methods resulted in a low probability of identifying the correct treatment arm.

    Conclusions:

    • While factorial designs can offer enhanced efficiency, predicting favorable conditions for their success is challenging.
    • Potential gains in efficiency must be carefully weighed against the risk of reduced statistical power and incorrect conclusions.
    • Researchers should consider the potential impact on arriving at the correct conclusion under various scenarios when implementing factorial designs.